PARIS, May 13, 2025 /CNW/ -- Eligo Bioscience, a biotechnology company pioneering the development of novel genetic medicines, today announced it has secured a $5 million grant from the French ...

LIPHOOK, United Kingdom, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Lumi Global, a global leader in technology-driven governance and voting solutions, today announced the acquisition of Eligo, Italy’s leading ...

PARIS--(BUSINESS WIRE)--Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful ...

PARIS, Jan. 11, 2021 /PRNewswire/ -- Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed at advancing ...

(RTTNews) - Eligo Bioscience SA has reached a research and option agreement with GlaxoSmithKline (GSK) aimed at advancing Eligobiotics for the treatment or prevention of acne vulgaris with a ...

(MENAFN- GetNews) Eligo eVoting announces the U.S. release of its secure digital voting protocol, designed with low coercion and end-to-end verifiability to ensure transparency and voter autonomy ...

This grant follows recent key milestones for Eligo, including the publication of its microbiome base-editing platform in Nature, securing multiple foundational patents covering in situ editing of the ...

(MENAFN- PR Newswire) PARIS, Jan. 11, 2021 /PRNewswire/ -- Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed ...

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under France 2030 strategy, operated on behalf of the French ...